Ramipril (Nexrami (10 mg)) is an angiotensin-converting enzyme (ACE) inhibitor, used alone or in combination with other medications to treat high blood pressure. It is also used to reduce the risk of ...

In patients who have vascular disease or high-risk diabetes without heart failure, angiotensin-converting–enzyme (ACE) inhibitors reduce mortality and morbidity from cardiovascular causes, but the ...

The evidence for the efficacy of ramipril in relieving the symptoms of peripheral arterial disease is very limited. Two small RCTs (Ahimastos et al. 2006, n=40 and Shahin et al. 2013a, n=33) found ...

This multicenter, randomized, double blind clinical trial was conducted in the Internal Medicine and Therapeutics Department at the University of Pavia and in the G Descovich Atherosclerosis Study ...

March 31, 2008 (Chicago, IL) - The angiotensin receptor blocker (ARB) telmisartan (Micardis, Boehringer Ingelheim) was "noninferior" to the ACE inhibitor ramipril in patients with vascular disease or ...

OTTAWA, ONTARIO, Mar 19, 2012 (MARKETWIRE via COMTEX) -- The issue: Health Canada is informing Canadians that Apotex Incorporated is conducting a voluntary recall of one lot of Apo-Ramipril 5mg ...

Please provide your email address to receive an email when new articles are posted on . Presenting data from the trial during the American College of Cardiology Scientific Session, Marc Pfeffer, MD, ...

Peripheral arterial disease, also known as peripheral vascular disease, is a condition in which arteries that carry blood to the legs (or less commonly the arms) are narrowed or blocked. The usual ...